1. Home
  2. OCX vs ANEB Comparison

OCX vs ANEB Comparison

Compare OCX & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCX
  • ANEB
  • Stock Information
  • Founded
  • OCX 2009
  • ANEB 2020
  • Country
  • OCX United States
  • ANEB United States
  • Employees
  • OCX N/A
  • ANEB N/A
  • Industry
  • OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • OCX Health Care
  • ANEB Health Care
  • Exchange
  • OCX Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • OCX 35.1M
  • ANEB 36.7M
  • IPO Year
  • OCX N/A
  • ANEB 2021
  • Fundamental
  • Price
  • OCX $2.38
  • ANEB $1.33
  • Analyst Decision
  • OCX Buy
  • ANEB Buy
  • Analyst Count
  • OCX 3
  • ANEB 1
  • Target Price
  • OCX $4.42
  • ANEB $8.00
  • AVG Volume (30 Days)
  • OCX 79.0K
  • ANEB 12.3K
  • Earning Date
  • OCX 11-12-2024
  • ANEB 02-21-2025
  • Dividend Yield
  • OCX N/A
  • ANEB N/A
  • EPS Growth
  • OCX N/A
  • ANEB N/A
  • EPS
  • OCX N/A
  • ANEB N/A
  • Revenue
  • OCX $709,000.00
  • ANEB N/A
  • Revenue This Year
  • OCX N/A
  • ANEB N/A
  • Revenue Next Year
  • OCX $106.34
  • ANEB N/A
  • P/E Ratio
  • OCX N/A
  • ANEB N/A
  • Revenue Growth
  • OCX N/A
  • ANEB N/A
  • 52 Week Low
  • OCX $1.92
  • ANEB $0.80
  • 52 Week High
  • OCX $3.48
  • ANEB $3.30
  • Technical
  • Relative Strength Index (RSI)
  • OCX 59.56
  • ANEB 36.62
  • Support Level
  • OCX $1.95
  • ANEB $1.45
  • Resistance Level
  • OCX $2.60
  • ANEB $1.61
  • Average True Range (ATR)
  • OCX 0.19
  • ANEB 0.13
  • MACD
  • OCX 0.05
  • ANEB -0.02
  • Stochastic Oscillator
  • OCX 66.41
  • ANEB 0.00

About OCX Oncocyte Corporation

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: